This paper is in the following e-collection/theme issue:

Research Letter (38) Chatbots and Conversational Agents (532) mHealth for Screening (214) Breast Cancer (209) Artificial Intelligence (1383) Innovations and Technology for Cancer Prevention and Screening (149) Usability of Apps and User Perceptions of mHealth (983)

Published on in Vol 26 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/48914, first published .
Preliminary Screening for Hereditary Breast and Ovarian Cancer Using an AI Chatbot as a Genetic Counselor: Clinical Study

Preliminary Screening for Hereditary Breast and Ovarian Cancer Using an AI Chatbot as a Genetic Counselor: Clinical Study

Preliminary Screening for Hereditary Breast and Ovarian Cancer Using an AI Chatbot as a Genetic Counselor: Clinical Study

Authors of this article:

Ann Sato1, 2 Author Orcid Image ;   Eri Haneda1 Author Orcid Image ;   Yukihiko Hiroshima3, 4 Author Orcid Image ;   Hiroto Narimatsu1, 2, 5 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Ann Sato   1, 2 , MSc ;   Eri Haneda   1 , MSc ;   Yukihiko Hiroshima   3, 4 , MD, PhD ;   Hiroto Narimatsu   1, 2, 5 , MD, PhD

1 Department of Genetic Medicine, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan

2 Graduate School of Health Innovation, Kanagawa University of Human Services, Kawasaki, Kanagawa, Japan

3 Department of Cancer Genome Medicine, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan

4 Advanced Cancer Therapy Division, Kanagawa Cancer Center Research Institute, Yokohama, Kanagawa, Japan

5 Cancer Prevention and Cancer Control Division, Kanagawa Cancer Center Research Institute, Yokohama, Kanagawa, Japan

Corresponding Author: